Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2009-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2009.02.037PMID 19250825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.

  2008cited by this paper
• Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy

  2008cited by this paper
• Aldose reductase, still a compelling target for diabetic neuropathy.

  2008cited by this paper
• Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites

  2007cited by this paper
• The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient

  2007cited by this paper
• Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.

  2005cited by this paper
• Factorizing selectivity determinants of inhibitor binding toward aldose and aldehyde reductases: structural and thermodynamic properties of the aldose reductase mutant Leu300Pro-fidarestat complex.

  2005cited by this paper
• Clinical Potential of Aldose Reductase Inhibitors in Diabetic Neuropathy

  2004cited by this paper
• Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications.

  2004cited by this paper
• Biochemical Pathways for Microvascular Complications of Diabetes Mellitus

  2003cited by this paper
• Methylglyoxal Modification of Protein

  1999cited by this paper
• Inhibition of human aldehyde reductase by drugs for testing the function of liver and kidney.

  1999cited by this paper
• Overexpression of aldehyde reductase protects PC12 cells from the cytotoxicity of methylglyoxal or 3-deoxyglucosone.

  1998cited by this paper
• The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.

  1997cited by this paper
• Nonenzymatic glycation of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells.

  1996cited by this paper
• Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway.

  1996cited by this paper
• Glycation, Glycoxidation, and Cross-Linking of Collagen by Glucose: Kinetics, Mechanisms, and Inhibition of Late Stages of the Maillard Reaction

  1994cited by this paper
• Hyperglycemic Pseudohypoxia and Diabetic Complications

  1993cited by this paper
• Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression.

  1993cited by this paper
• Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression

  1993cited by this paper
• Aldehyde reductase is a major protein associated with 3-deoxyglucosone reductase activity in rat, pig and human livers.

  1991cited by this paper
• Textbook of Diabetes

  1991cited by this paper

• Mechanism of Inhibitory Effects of Phellodendrine on Diabetes Mellitus Using Molecular Docking Method

  2024cites this paper
• Novel acetic acid derivatives containing quinazolin‐4(3H)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors

  2023cites this paper
• Gaining deeper insights into 2,5-disubstituted furan derivatives as potent α-glucosidase inhibitors and discovery of putative targets associated with diabetes diseases using an integrative computational approach

  2022cites this paper
• Advanced Bioinformatics Tools in the Pharmacokinetic Profiles of Natural and Synthetic Compounds with Anti-Diabetic Activity

  2021cites this paper
• Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.

  2020cites this paper
• Three-Component One-Pot Synthesis of Highly Functionalized Bis-Indole Derivatives

  2019cites this paper
• Structural analysis of protein tyrosine phosphatase 1B reveals potentially druggable allosteric binding sites

  2018cites this paper
• Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.

  2017cites this paper
• Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study.

  2017cites this paper
• Does inhibition of aldose reductase contribute to the anti-inflammatory action of setipiprant?

  2017cites this paper
• Identification of novel aldose reductase inhibitors based on carboxymethylated mercaptotriazinoindole scaffold.

  2015cites this paper
• [5-(Benzyloxy)-1H-indol-1-yl]acetic acid, an aldose reductase inhibitor and PPARγ ligand.

  2015cites this paper
• Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.

  2015cites this paper
• A novel water-soluble benzothiazole derivative BD926 inhibits human activated T cell proliferation by down-regulating the STAT5 activation.

  2015cites this paper
• Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.

  2015cites this paper
• Could MM-GBSA be accurate enough for calculation of absolute protein/ligand binding free energies?

  2013cites this paper
• BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway

  2013cites this paper
• A one-pot reaction to synthesize two types of fluorescent materials containing benzothiazolyl moiety.

  2013cites this paper
• Docking Studies of Chlorogenic Acid against Aldose Redutcase by using Molgro Virtual Docker Software

  2013influential citation
• Pharmacophore modeling, molecular docking, and molecular dynamics simulation approaches for identifying new lead compounds for inhibiting aldose reductase 2

  2012cites this paper
• Aldose reductase inhibitory principles from the whole plant of Hybanthus enneaspermus (Linn) F. Muell

  2012cites this paper
• Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.

  2012cites this paper
• Radiosynthesis of C-11 Labeled Auxin (3-Indolyl[1-11C]acetic Acid) and Its Derivatives from Gramine

  2011cites this paper
• Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.

  2011cites this paper
• Synthesis of the human aldose reductase inhibitor rubrolide L

  2010cites this paper